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Highlights 
 Smokers showed cortical thinning in multiple brain regions relative to Non-Smokers. 
 Greater cigarette pack years was related to thinner cortex in multiple regions. 
 In Smokers, impulsivity and poorer decision-making was related to thinner cortex. 
 
Abstract  
Background: Magnetic resonance imaging studies of cigarette smoking-related effects on 
human brain structure primarily focused on cortical volumes. Much less is known about the 
effects of smoking on cortical thickness. Smokers and Non-smokers were compared on regional 
cortical thickness. We predicted smokers would demonstrate greater age-related thinning 
localized to anterior frontal regions that serve as nodes for the executive, salience, and emotional 
regulation networks (ESER regions) and those demonstrating significant atrophy in early 
Alzheimer’s Disease (AD regions). 
Methods: Non-smokers (n = 41) and smokers (n = 41), 22-70 years of age, completed a 4 Tesla 
MRI study. Regional cortical thickness was quantitated via FreeSurfer. In smokers, associations 
between smoking severity, decision-making, impulsivity, and regional cortical thickness were 
examined. 
Results: Smokers demonstrated cortical thinning in the medial and lateral OFC, insula, 
entorhinal, fusiform, middle temporal, and Composite AD regions. In Smokers, greater pack-
years were associated with thinner lateral OFC, middle temporal, inferior parietal, fusiform, 
precuneus, and Composite AD regions. In Smokers, poorer decision-making/greater risk taking 
was related to thinner cortices in caudal ACC, rostral middle frontal and superior frontal gyri, 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
 
and Composite ESER. Higher self-reported impulsivity was associated with thinner rostral and 
caudal ACC. 
Conclusions: This study provides additional evidence that cigarette smoking is associated with 
thinner cortices in regions implicated in the development and maintenance of substance use 
disorders and in regions demonstrating significant atrophy in early AD. The novel structure-
function relationships in Smokers further our understanding of the neurobiological substrates 
potentially underlying the neuropsychological abnormalities documented in smokers. 
 
 
Keywords: Cigarette Smoking; Magnetic Resonance Imaging; Cortical Thickness; Decision-
Making; Impulsivity; FreeSurfer 
 
 1. Introduction  
  The link between cigarette smoking and markedly increased risk for pulmonary, cardiac, 
and vascular disease as well as for multiple forms of cancer in humans is essentially indisputable 
(CDC, 2004). A growing body of evidence also indicates that smoking, in otherwise healthy 
individuals, is associated with neurobiological and neurocognitive abnormalities that are not 
directly related to the foregoing diseases (Azizian et al., 2009; Durazzo et al., 2014a; Durazzo et 
al., 2010; Durazzo et al., 2017; Sharma and Brody, 2009). Most magnetic resonance (MR) 
studies investigating the neurobiological consequences of cigarette smoking have focused on 
volume/density of cortical gray matter (GM) and/or subcortical nuclei (see Durazzo et al., 2010; 
Pan et al., 2013; Sutherland et al., 2016 for review). Smaller volumes or lower density in dorsal 
and ventromedial prefrontal cortex, orbitofrontal cortex, insula, thalamus, and cerebellum were 
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the most consistently reported findings (Durazzo et al., 2010; Pan et al., 2013; Sutherland et al., 
2016); structural abnormalities in these regions are also apparent in alcohol and substance use 
disorders (see Buhler and Mann, 2011; Cadet et al., 2014 for review) The anterior frontal, 
insular, and subcortical regions that show structural abnormalities in smokers are critical nodes 
in the executive, salience, and emotional regulation networks (Seeley et al., 2007; Williams, 
2016). Additionally, in smokers, studies have reported smaller volumes (Almeida et al., 2011; 
Almeida et al., 2008; Peng et al., 2018) in adults and elders, greater longitudinal volume loss 
over 2 years in elders (Durazzo et al., 2012), and accelerated age-related volume loss in middle-
aged adults (Durazzo et al., 2013a; Durazzo et al., 2017) in cortical and subcortical regions that 
show atrophic changes in those with mild cognitive impairment and early-stage Alzheimer’s 
Diseasedisease (Vemuri et al., 2010). Correspondingly, chronic smoking during adulthood is 
associated with significantly elevated risk for Alzheimer’s Diseasedisease and related 
neuropathological changes (see Durazzo et al., 2014a for review). The cumulative body of 
research suggests chronic smoking-related structural abnormalities also show considerable 
overlap with regions that manifest atrophic changes in alcohol/substance use disorders and 
Alzheimer’s Diseasedisease.  
  While most MR studies have investigated the consequences of smoking on cerebral 
volume, fewer studies have examined smoking-related effects on cortical thickness. Cortical 
thickness is believed to reflect the number and density of cells in a column (Rakic, 1988; 2008) 
and/or represent neuronal cell body size, the number of spines and synapses, and the degree of 
myelination (Eickhoff et al., 2005; Fjell and Walhovd, 2010). Cortical thickness is genetically 
and phenotypically distinct from cortical surface area and volume (Kremen et al., 2010; Panizzon 
et al., 2009; Winkler et al., 2010), and it is related to neurocognition in healthy adults and 
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adolescents (Choi et al., 2008; Dickerson et al., 2008; Fjell et al., 2006; Schilling et al., 2013; 
Walhovd et al., 2006) and those with a cocaine use disorder (Makris et al., 2008a). Cortical 
thickness is reputed to be more sensitive to neurodegenerative processes than cortical volumes 
(Hutton et al., 2009); therefore, this morphometric may increase the ability to detect more subtle 
structural abnormalities than volumes or density measures and/or be differentially affected by 
addictive disorders compared to volumes and surface area (Durazzo et al., 2011b; Wang et al., 
2016). Taken together, cortical thickness may serve as a proxy for the integrity of cortical 
cytoarchitecture (Makris et al., 2007). Kuhn and colleagues (Kuhn et al., 2010) reported that 
adult smokers had thinner left medial orbitofrontal cortex (OFC) than never-smokers. Karama 
and colleagues (Karama et al., 2015) reported wide-spread reduction of thickness across the 
cortex, with the greatest thinning in anterior frontal regions in elder active smokers relative to 
never smokers, after adjusting for vascular risk factors. In a sample of late adolescent/young 
adults, Li and associates (Li et al., 2015) reported that smokers demonstrated significant cortical 
thinning in the left caudal anterior cingulate cortex (ACC), right lateral OFC, left insula, left 
middle temporal gyrus, right inferior parietal lobule, and right parahippocampus. In the above 
studies, greater pack-years was associated with thinner cortices in the regions that also showed 
significantly thinner cortices in smokers relative to never-smokers. However, associations 
between regional cortical thickness and clinically relevant aspects of decision-making and 
impulsivity, which are key cognitive components in the initiation and maintenance of addictive 
disorders (Fineberg et al., 2010; Verdejo-Garcia and Bechara, 2009), were not examined in these 
studies. 
 The risk for smoking-related diseases increases with years of smoking (CDC, 2004), 
which is inextricably linked to age. In healthy adults, increasing age is associated with declines 
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in regional cortical thickness (Fjell et al., 2015; Storsve et al., 2014). In the few previous studies 
investigating smoking-related effects on cortical thickness, mean thickness differences were 
examined between smokers and never-smokers. While this approach permitted testing for the 
effect of smoking status (i.e., smoker vs. never-smoker) collapsed across the age range of the 
participants, no study specifically tested for a smoking status by age interaction. Our previous 
neuroimaging studies showed that, in healthy participants 25-70 years of age, smokers had both 
lower mean values and greater age-related declines of anterior frontal brain metabolite 
concentrations (N-acetylaspartate and glutamate) and hippocampal and subcortical volumes 
(Durazzo et al., 2016c; Durazzo et al., 2013a; Durazzo et al., 2017). In these studies, greater 
cigarette pack-years was related to lower metabolite levels and smaller regional volumes. The 
greater age-related declines apparent in smokers suggest that chronic smoking amplified the 
effects of normal aging on multiple aspects of neurobiology. These neurobiological 
abnormalities may influence reward processing and response to smoking cessation interventions 
via alterations of the integrity of structural and/or functional connectivity in frontolimbic and/or 
frontostriatal circuitry (Froeliger et al., 2015; Hong et al., 2009; Li et al., 2017; Sutherland et al., 
2013; Sutherland et al., 2016; Sweitzer et al., 2016). Based on previous neuroimaging findings 
from our group and others, we predicted that adult smokers would demonstrate greater age-
related cortical thinning and lower mean thickness in anterior frontal regions that serve as nodes 
for the executive, salience, and emotional regulation networks (hereafter referred to as ESER 
regions) as well as in posterior regions that show significant atrophy in early-stage Alzheimer’s 
Diseasedisease (hereafter referred to as AD regions). In smokers, we hypothesized that higher 
pack-years are related to thinner cortices in ESER and AD regions. We also predicted that poorer 
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performance on measures of decision-making/risk-taking and impulsivity are associated with 
thinner cortices in ESER regions of smokers.  
 2. Methods 
 2.1 Participants 
 Eighty-two healthy, community-dwelling participants [41 non-smokers (seven females) 
and 41 smokers (six females)] were recruited via electronic billboards and word-of-mouth. 
Participants were between the ages of 22 and 70 (see Table 1 for demographics). Participants 
gave written informed consent according to the Declaration of Helsinki, and all procedures were 
approved by the University of California San Francisco and the San Francisco VA Medical 
Center.  
 Detailed inclusion/exclusion criteria are described elsewhere (Durazzo et al., 2011a). In 
summary, participants were screened for the following: history of neurologic (e.g., seizure 
disorder, neurodegenerative disorder, demyelinating disorder, closed head trauma with loss of 
consciousness), and general medical (e.g., hypertension, myocardial infarction, Type-1 or 2 
diabetes, cerebrovascular accident, any form of cancer) and psychiatric (i.e., mood, thought, 
anxiety, trauma and stressor-related, substance/alcohol use disorders) conditions known or 
suspected to influence neurocognition and/or brain neurobiology. Non-smoking participants 
never smoked (n = 36) or smoked less than 40 cigarettes during their lifetime and used no 
tobacco products for at least 10 years prior to study (n = 5). All smoking participants were 
actively smoking at the time of assessment, smoked at least 10 cigarettes/day for 5 years or more, 
and had no periods of smoking cessation greater than 1 month in the 5 years prior to study with 
no concurrent use of other tobacco products. No smoker was engaged in any pharmacological 
and/or behavioral smoking cessation program at the time of study.  
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 2.2 Medical, psychiatric, substance, alcohol consumption and behavioral assessment 
 Participants completed the screening section of the Structured Clinical Interview for 
DSM-IV Axis I disorders, Patient Edition, Version 2.0 [SCID-I/P; (First et al., 1998)] as well as 
an in-house questionnaire designed to screen for medical, psychiatric, neurological and 
developmental conditions that may affect neurocognition or neurobiology (see Durazzo et al., 
2004). Participants completed standardized questionnaires assessing substance use [in-house 
questionnaire assessing substance type, quantity and frequency of use (Abe et al., 2013)] and 
lifetime alcohol consumption [Lifetime Drinking History, LDH; (Skinner and Sheu, 1982; Sobell 
et al., 1988)]. From the LDH, average number of drinks per month over lifetime (one drink 
defined as containing 13.6 grams of pure ethanol) was calculated. Participants also completed 
self-report measures of depressive [(Beck Depression Inventory, BDI; (Beck, 1978)] and anxiety 
symptomatology [(State-Trait Anxiety Inventory, form Y-2, STAI; (Spielberger et al., 1977)]. 
Smokers completed a measure of nicotine dependence level [Fagerström Test for Nicotine 
Dependence (FTND; Heatherton et al., 1991)], self-reported the number of cigarettes currently 
smoked per day, and number of years of smoking over their lifetime. Pack-years (number of 
cigarettes per day/20) x total number of years of smoking was calculated for smokers. An 
equivalent frequency of Smokers and Non-Smokers (30%) reported intermittent “recreational” 
use (i.e., ≤ 3 episodes/month) of cannabis or cocaine during late adolescence or early adulthood. 
Prior to assessment, participants’ urine was tested for five common illicit substances (THC, 
opiates, PCP, cocaine, amphetamines), and participants were breathalyzed for recent ethanol 
consumption. No participant was positive for the above common substances or ethanol at the 
time of assessment. Smokers and Non-Smokers completed the Iowa Gambling Task, [IGT 
(Bechara, 2007)], a task-based measure of decision-making and risk-taking, and the Barrett 
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Impulsivity Scale-11 [BIS-11 (Patton et al., 1995)], a self-report measure of aspects of trait 
impulsivity.  
 2.3 Magnetic Resonance Imaging (MRI) acquisition and processing 
 Morphological MRI data were acquired on a 4.0 Tesla Bruker MedSpec system using an 
8-channel transmit-receive head coil (Siemens, Erlangen, Germany). A Magnetization Prepared 
Rapid Gradient (TR/TE/TI = 2300/3/950 ms, 7o flip angle, 1.0 x 1.0 x 1.0 mm3 resolution) 
sequence was used to acquire 3D sagittal T1-weighted images for morphological analyses. The 
publicly available FreeSurfer (v5.1) segmentation and cortical surface reconstruction methods 
were used to obtain thickness for 34 bilateral regions (mm) and total intracranial volume (ICV; 
mm3) (Dale et al., 1999; Fischl and Dale, 2000; Fischl et al., 2004; Fischl et al., 1999). All 
segmented subcortical and parcellated cortical T1-weighted images were visually inspected by 
one of the authors (TCD) for accuracy; any errors in segmentation/parcellation were manually 
edited, reprocessed, and reinspected as previously described (Durazzo et al., 2014c). The final 
segmented subcortical and parcellated cortical volumes passed all quality requirements (Durazzo 
et al., 2014c). Analyses focused on cortical components that serve as nodes for the ESER (Seeley 
et al., 2007; Williams, 2016) and included the bilateral rostral and caudal ACC, medial and 
lateral OFC, rostral and caudal middle frontal gyri, and superior frontal gyri. An ESER 
composite thickness was created by calculating the surface area-weighted average of all ESER 
ROIs (Durazzo et al., 2014c). AD ROIs included the bilateral entorhinal cortex, fusiform gyri, 
inferior temporal, inferior parietal lobule, isthmus and posterior cingulate, and precuneus. An AD 
composite thickness was created by calculating the surface area-weighted average of all AD 
ROIs (Durazzo et al., 2014c). 
 2.4 Statistical Analyses 
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 2.4.1 Demographic and clinical variables. Demographic and clinical variables were 
compared between smokers and non-smokers with t-tests and Fisher’s Exact Test where 
indicated.  
 2.4.2 Comparisons of Smokers and Non-smokers on regional ESER and AD thickness.  
To test our hypothesis of greater age-related regional cortical thinning in smokers, we employed 
generalized linear modeling (GENLIN) and specifically tested for a smoking status (smoker vs. 
non-smoker) by age interaction. In preliminary analyses comparing smokers and non-smokers, 
no consistent pattern emerged for lateralized differences in the ROIs; therefore, results for the 
average of the left and right hemisphere for each ESER, AD, and Non-ESER/AD ROIs are 
presented. Dependent measures were ROI thickness, and covariates included age, education, BDI 
score, ICV, average lifetime drinks/month (smokers and non-smokers were different on 
education, BDI score, and average lifetime drinks/month; see Table 1 and section 3.1. below). 
Although cortical thickness is reported to not show the same strong magnitude of relationships 
with ICV as surface area and volume (e.g., Kremen et al., 2010; Panizzon et al., 2009), cortical 
thickness was significantly inversely related to ICV in our previous studies of individuals with 
alcohol use disorder and healthy controls (Durazzo et al., 2013b; Durazzo et al., 2011b). Main 
effects and interactions between smoking status and age and follow-up t-tests (two-tailed) were 
considered significant at p < .05. In all previous neuroimaging-based reports with this cohort 
(Durazzo et al., 2016c; Durazzo et al., 2013a; Durazzo et al., 2017), we conservatively corrected 
t-tests for multiple comparisons. Given our a priori predictions and our consistent findings of 
neurobiological and neurocognitive abnormalities in smokers in the ROIs investigated in this 
study, follow-up t-tests were considered statistically significant at p < .05, uncorrected. Effect 
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sizes were calculated with Cohen’s d (Cohen, 1988) for statistically significant differences in 
ROI thickness between smokers and non-smokers.  
 2.4.3 Comparisons of Smokers and Non-smokers on non-ESER/AD ROI thickness. 
Smokers and Non-Smokers were compared on regions outside the specified ESER and AD ROIs 
to determine if smoking-related effects on cortical thickness were localized to ESER and AD 
ROIs or were more widely distributed. GENLIN was used for these comparisons, and, consistent 
with analyses of Smokers and Non-Smokers on ESER and AD ROIs, we specifically tested for a 
smoking status (smoker vs. non-smoker) by age interaction and employed the same covariates. 
Main effects and interactions between smoking status and age and follow-up t-tests (two-tailed) 
were considered significant at p < .05 in these exploratory analyses. The following cortical 
regions were compared: banks of superior temporal gyrus, cuneus, frontal pole, lingual, 
paracentral, pars opercularis, pars triangularis, pericalcarine, post central, precentral, superior 
parietal, superior temporal, and transverse temporal cortices. 
 2.4.4 Associations between ESER, AD, and non-ESER/AD ROI thickness and smoking 
severity measures. In Smokers, associations between the ESER, AD, and Non-ESER/AD ROI 
thickness and cigarette pack-years (measure of exposure magnitude) and FTND score (measure 
of nicotine dependence level) were examined by linear regression (partial correlations reported) 
adjusting for age, education, and ICV. A two-tailed p < .05 was considered statistically 
significant, and only associations of at least moderate magnitude (i.e., r ≥ |0.30|) were reported. 
 2.4.5 Associations between ESER, AD, and Non-ESER/AD ROI thickness and decision-
making/risk-taking and impulsivity in Smokers and Non-Smokers. Associations of ESER and AD 
ROI thickness and performance on the IGT Total Score (raw score) and BIS-11 total score, 
attentional impulsivity, motor impulsivity, and non-planning impulsivity were separately 
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examined in Smokers and Non-Smokers with linear regression (partial correlations reported) 
adjusted for age, education, and ICV. A two-tailed p < .05 was considered statistically 
significant, and only associations of at least moderate magnitude (i.e., r ≥ |0.30|) were reported. 
See Durazzo et al. (2016c) for comparisons of Smokers and Non-Smokers from this cohort on 
the IGT and BIS-11, in which Smokers performed more poorly on the IGT (indicative of poorer 
decision-making/greater risk taking) and showed higher BIS-11 scores (indicative of greater 
impulsivity) than Non-Smokers. 
 3. Results 
 3.1 Participant demographics and clinical variables 
 Smokers and Non-Smokers were equivalent on age, sex, percent of Caucasians, and level 
of anxiety symptomatology. Smokers had significantly lower educational level, higher BDI 
scores, and consumed more average lifetime alcoholic drinks per month (all p < .05). Although 
statistically different between groups, the average BDI score for both groups was in the normal 
range (i.e., < 10) and well below the cutoff for mild depressive symptomatology (Richter et al., 
1998). Participant alcohol consumption did not approach a hazardous level [see (McKee et al., 
2007; Mertens et al., 2005)] (see Table 1). All females were pre-menopausal, by self-report. 
 3.2 Comparisons of Smokers and Non-Smokers on ESER and AD ROI cortical 
thickness 
 Models containing smoking status, age, and ICV were significant predictors of thickness 
in the medial OFC [2(3) = 9.56, p = .023], lateral OFC [2(3) = 13.5, p = .004], entorhinal 
cortex [2(3) = 14.3, p = .003], fusiform gyrus [2(3) = 39.4, p < .001], and middle temporal 
gyrus [2(3) = 37.2, p < .001]; greater age was related to thinner cortex, and larger ICV was 
associated with thicker cortex in these ROIs (all p < .01). The model with smoking status, age, 
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and lifetime average drinks per month showed they were significant predictors of insula 
thickness [2(3) = 35.3, p < .001]; greater age and lifetime average drinks per month were related 
to thinner insular cortex (all p < .05). The model with smoking status, age, and education showed 
them to be predictors of Composite AD ROI thickness [2(3) = 44.3, p < .001]; greater age was 
related to thinner Composite AD ROIs and higher education, and ICV was associated with 
thicker Composite AD ROIs (all p < .05). Smokers demonstrated thinner cortices than Non-
Smokers in all above ROIs (see Fig. 1 and 2). BDI score was not a significant predictor of 
thickness in any region. The smoking status x age interactions were not significant for any ROI 
examined. 
 3.3 Comparisons of Smokers and Non-Smokers on Non-ESER and AD cortical ROI 
thickness 
 No significant smoking status x age interactions or main effects for smoking status were 
observed for any Non-ESER/AD ROI. 
 3.4 Associations of pack-years and nicotine dependence and regional thickness in 
Smokers 
 3.4.1 ESER and AD ROIs. In Smokers, higher pack-years was related to thinner cortices 
in the middle temporal (r = -0.50, p = .001; see Fig. 3), inferior parietal (r = -0.42, p = .010), 
fusiform (r = -0.41, p = .013), precuneus (r = -0.37, p = .024), lateral OFC (r = -0.33, p = .047), 
and composite AD (r = -0.40, p = .013) ROIs. No significant associations were observed between 
FTND score and ESER or AD ROIs. 
 3.4.2 Non-ESER/AD ROIs. There were no significant associations between pack-years 
and FTND score for any region. 
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 3.5 Associations of measures of decision-making and impulsivity with regional 
thickness in Smokers and Non-Smokers 
 3.5.1 ESER and AD ROIs. In Smokers, lower IGT Net Total Score (indicative of poorer 
decision-making/lower risk-taking) was associated with thinner cortices in the superior frontal 
gyrus (r = 0.51, p = .005; see Fig. 4), caudal ACC (r = 0.44, p = .020), rostral middle frontal 
gyrus (r = -0.43, p = .022), and composite ESER (r = 0.43, p = .022). On the BIS-11, higher non-
planning impulsivity (r = -0.35, p = .046), motor impulsivity (r = -0.38, p = .028), and BIS-11 
total score (r = -0.43, p = .022) were related to thinner rostral ACC, and higher non-planning 
impulsivity was associated with thinner caudal ACC (r = -0.37, p = .030). The associations 
between the IGT, BIS-11, and above ROIs largely showed equivalent magnitudes for the left and 
right hemisphere for both groups (data not shown). There were no significant relationships 
between IGT, BIS-11, and ESER or AD ROI thickness in Non-Smokers. 
 3.5.2 Non-ESER/AD. There were no significant associations between IGT Net Total 
Score, BIS-11, and cortical thickness in the Non-ESER/AD ROIs in Smokers and Non-Smokers. 
 4. Discussion 
 The primary findings of this 4 Tesla quantitative MRI study were: 1) Otherwise healthy 
adult Smokers demonstrated significant cortical thinning compared to Non-Smokers in the 
medial and lateral OFC, insula, entorhinal, fusiform, middle temporal, and Composite AD ROIs. 
Smokers and Non-Smokers did not show statistically significant differences in thickness in areas 
outside ESER and AD ROIs. 2) In Smokers, greater pack-years were associated with thinner 
cortices in the lateral OFC, middle temporal, inferior parietal, fusiform, precuneus, and 
Composite AD ROIs. 3) In Smokers, poorer decision-making/lower risk taking was related to 
thinner cortices in the caudal ACC, rostral middle frontal gyrus, superior frontal gyrus, and 
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Composite ESER. Higher measures of impulsivity were associated with thinner cortices in the 
rostral and caudal ACC in Smokers. 
 The overall pattern of findings indicates the regional cortical thinning and associations 
with pack-years demonstrated by this group of smokers were limited to ESER and AD ROIs. 
These results are highly consistent with the few previous published studies of smoking-related 
effects on regional cortical thickness in non-clinical populations (Karama et al., 2015; Kuhn et 
al., 2010; Li et al., 2015) and also congruent with studies investigating the effects of smoking on 
regional brain volumes (see Durazzo et al., 2010; Pan et al., 2013; Sutherland et al., 2016). 
Contrary to predictions, smokers did not show greater age-related cortical thinning in any ROI, 
unlike the greater age-related decline in hippocampal and subcortical volumes (Durazzo et al., 
2013a; Durazzo et al., 2017) and brain metabolites (Durazzo et al., 2016c) previously observed 
in this cohort. As this study excluded individuals with clinically significant smoking-related 
morbidity, it is possible that the age-related effects on cortical thickness were underestimated in 
this otherwise healthy cohort (Durazzo et al., 2014a), and/or the age range was not sufficient to 
yield a smoking status by age interaction. 
 In ESER regions, Smokers showed thinning of the medial and lateral OFC and insula. 
Collectively, the OFC is implicated in appraisal of stimulus saliency and representation of 
reward magnitude, self-monitoring, emotional and impulse regulation, and aspects of decision-
making and executive skills (Fettes et al., 2017; Kringelbach and Rolls, 2004; Rolls and 
Grabenhorst, 2008). The insula is involved in monitoring internal physiological states/sensations 
(i.e., interoception), adjustment of attentional control based on internal physiological states 
(Naqvi and Bechara, 2010; Paulus, 2007), and is a major node in the salience network (Williams, 
2016). A double blind, placebo-controlled trial of repetitive transcranial magnetic stimulation 
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found that high frequency stimulation (one session/day for 13 days) to the bilateral insula and 
dorsolateral prefrontal cortex was associated with a smoking cessation rate of 44% immediately 
after treatment and 33% cessation rate in the 6 months following the treatment (Dinur-Klein et 
al., 2014). In AD regions, Smokers demonstrated thinner cortices in the entorhinal, fusiform, and 
middle temporal gyrus as well as across the collective AD ROIs. These regions subserve aspects 
of face and body recognition, color processing, word recognition (left hemisphere), and 
declarative and spatial memory (Grill-Spector and Weiner, 2014; Kolb and Whishaw, 2009). 
Compromised structural integrity of the ESER and AD cortical regions, as indicated by the 
reduced thickness, may contribute to the abnormalities observed in smokers in mood regulation, 
cue reactivity, impulse control, decision-making, learning and memory, executive skills 
(Durazzo et al., 2016c; Durazzo et al., 2010, 2011a; Fergusson et al., 2003), and to the altered 
functional connectivity (Fedota and Stein, 2015). 
 Greater pack-years showed moderate magnitude associations with thinner cortices in the 
lateral OFC, middle temporal, inferior parietal, fusiform, precuneus, and composite AD ROIs. 
The lateral OFC, middle temporal, fusiform, and Composite AD thicknesses were significantly 
reduced in Smokers, which suggests a cigarette dose/duration-response relationship. No 
significant associations were observed between pack-years and thickness in areas outside the 
ESER and AD ROIs. Increased smoking-related cerebral oxidative stress (see Durazzo et al., 
2016a; Durazzo et al., 2016b; Durazzo et al., 2014a; Durazzo et al., 2014b) and/or chronic 
nicotine exposure (see Durazzo et al., 2014a; Sutherland et al., 2016) are hypothesized to be 
fundamental mechanisms contributing to the structural and other neurobiological abnormalities 
observed in smokers. Replication in larger samples is required to determine if ESER and AD 
thickness show selective vulnerability to cigarette smoking and if premorbid or comorbid factors 
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not investigated in this study also contribute to the altered structural integrity observed in these 
regions. 
 In Smokers, poorer performance on the IGT (indicative of worse decision-making/greater 
risk-taking) was related to thinner cortices in the superior frontal gyrus, caudal ACC, rostral 
middle frontal gyrus, and composite ESER. These results are congruent with findings that tissue 
integrity of the dorsolateral and ventral medial prefrontal cortex and caudal ACC is related to 
performance on the IGT and other tasks/situations that require adjustment of goal-directed 
activity based on current environmental contingencies and anticipated future consequences (Bush 
et al., 2002; Clark et al., 2003; Fellows and Farah, 2005; Mega and Cummings, 1994). Higher 
aspects of self-reported impulsivity were related to thinner rostral and caudal ACC, which is 
consistent with the role of the ACC in monitoring and regulation of behavior and emotions (Bush 
et al., 2000; Goodkind et al., 2015; Williams, 2016). There were no significant associations 
between the IGT and BIS-11 and regional cortical thickness in Non-Smokers. The variance on 
the IGT and BIS-11 in Non-Smokers was relatively low, which appears to have restricted the 
range on these measures and likely dampened the magnitude of the associations between these 
measures and regional cortical thickness in this group. 
 This study has limitations that may affect the generalizability of the findings. 
Undocumented premorbid/comorbid group differences in lifestyle or subclinical biomedical 
conditions (e.g., poor diet and nutrition, lack of exercise, subclinical pulmonary or 
cardiovascular dysfunction) and/or genetic polymorphisms (Mon et al., 2013) may have 
influenced the results. Additionally, the small number of females precluded assessment of sex 
effects. 
 5. Conclusions 
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 This study provides additional evidence that cigarette smoking is associated with cortical 
thinning in regions implicated in the development and maintenance of substance use disorders as 
well as those that show significant atrophy in mild cognitive impairment and early AD. The 
novel structure-function relationships apparent in Smokers offer further insight into the 
neurobiological substrates related to the multiple neuropsychological abnormalities documented 
in cigarette smokers across adulthood. Smoking-related diseases kill at least 6 million individuals 
annually across the globe (WHO, 2015), and smoking is linked to increased risk for the 
development of Alzheimer’s Diseasedisease and related neuropathology (Durazzo et al., 2016a; 
Durazzo et al., 2016b; Durazzo et al., 2014a). Studies with elder adults suggest that at least 
partial recovery of regional morphological abnormalities is possible with extended smoking 
cessation (Almeida et al., 2011; Karama et al., 2015). Therefore, longitudinal research on the 
effects of chronic smoking on brain micro-and-macrostructural integrity, biochemistry, 
functional and structural connectivity, and their functional correlates is essential to inform the 
development of new treatment modalities to promote sustained smoking cessation (Ding et al., 
2018; Durazzo et al., 2014a; Sweitzer et al., 2016).  
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Figure Legends 
Figure 1. ESER Regions significantly different between Non-Smokers and Smokers. 
Figure 2. AD Regions significantly different between Non-Smokers and Smokers. 
Figure 3. Association of middle temporal gyri thickness and pack years in Smokers. 
Figure 4. Association of IGT Net Total Score and superior frontal gyri thickness in Smokers. 
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Figure 3. 
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Figure 4. 
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Table 1. Group Demographics, Alcohol and Cigarette Use Histories, and Self-Report Questionnaires 
____________________________________________________________________________
_ 
Measure   Non-smokers   Smokers     
                                               (n = 41)   (n = 41)    
  
____________________________________________________________________________
_ 
Age (years)   43.2 (12.3)    46.6 (11.0)    
Education (years)  16.1 (2.2)   14.8 (2.0)*   
Male (%)   83    85 
Caucasian (%)  56    68    
Lifetime average       
drinks/month   18 (11)   26 (14)*   
FTND    NA    5 (2)   
Pack-years   NA     25 (13)   
BDI    3 (3)     6 (4)*     
STAI     32 (7)    34 (9)     
Intracranial volume (cc) 1413 (203)   1425 (249)  
Note. BDI: Beck Depression Inventory. CON: Controls. FTND: Fagerstrom Tolerance Test for 
Nicotine Dependence. NA:  not applicable. STAI: State -trait Anxiety Inventory – Trait. *Smokers 
> Non-smokers, p < .05. Mean (SD). 
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